Philipp K Haber

5PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 22, 2024
Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinoma.

Philipp K Haber, Felix Krenzien, Kaya Sarıbeyoğlu

|Feb 13, 2023
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller

|Aug 23, 2022
Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Laura Torrens, Marc Puigvehí, Miguel Torres-Martín

|Dec 15, 2021
Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies.

Masatoshi Kudo, Robert Montal, Richard S Finn

|Jan 21, 2021
Atezolizumab plus Bevacizumab: A Novel Breakthrough in Hepatocellular Carcinoma.

Florian Castet, Catherine E Willoughby, Philipp K Haber

Pageof 1